Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

Online pharmacies will need a proper consultation, not just a patient's questionnaire, to prescribe jabs such as Mounjaro ...

Minnesota Senator Amy Klobuchar is urging the Trump administration to continue negotiating lower prescription drug prices for ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

You can find discounts on a variety of prescription drugs by searching GoodRx, but the ones compiled on the 30 under $30 ...

A 40-year-old man was arrested Saturday for suspicion of felony domestic battery resulting in substantial bodily harm, ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.

A Jan. 30 traffic stop led to an undercover drug investigation that resulted in the seizure of over two pounds of fentanyl ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.